Catalyst Wire Dossier Catalyst Wire Dossier

Roflumilast Cream 0.5%

roflumilast · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Roflumilast Cream 0.5%, covering 2016-12-05 to 2016-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis [Phase 2]

See pricing